Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/1995
12/26/1995US5478851 Hyperglycemic agent and antilipemic agent
12/26/1995US5478850 Thiazolidinedione derivatives
12/26/1995US5478847 Methods of use for inhibiting bone loss and lowering serum cholesterol
12/26/1995US5478844 Method of using aminocoumaran derivatives for treating cerebrovascular diseases
12/26/1995US5478835 Tricyclic compounds and intermediates thereof
12/26/1995US5478561 Process for the preparation of stable complex multiple emulsions of the water-oil water systems
12/26/1995CA2058771C Method of suppressing appetite by administration of tetrahydro-beta-carboline derivatives
12/26/1995CA1337803C Antibiotic produced by fermentation with amycolatopsis orientalis
12/21/1995WO1995034588A1 Cross-linked polymers for removing bile salts from a patient
12/21/1995WO1995034585A1 Process for removing bile salts from a patient and alkylated compositions therefor
12/21/1995WO1995034566A1 Lactam inhibitors of cholesterol esterase
12/21/1995WO1995034563A1 Pyrazolo and pyrrolopyridines
12/21/1995WO1995034557A1 2-AMINO-3-AROYL-BENZO[β]THIOPHENES AND METHOD OF MAKING THE SAME
12/21/1995WO1995034540A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
12/21/1995WO1995034539A1 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption
12/21/1995CA2192984A1 Lactam inhibitors of cholesterol esterase
12/21/1995CA2192459A1 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption
12/21/1995CA2192097A1 2-amino-3-aroyl-benzo¬.beta.|thiophenes and method of making the same
12/21/1995CA2152005A1 L-carnitine salt and compositions containing same
12/21/1995CA2150407A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
12/20/1995EP0687296A1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals
12/20/1995EP0645997B1 Cosmetic containing phospholipids and fluorocarbon compounds
12/20/1995EP0462258B1 Ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
12/20/1995CN1113491A Novel hydroxylamines with hypoglycemic activity
12/20/1995CN1113485A Process for the production of medicaments containing substituted pyridyl-dihydroxy-heptenonic acid or its salts
12/19/1995US5476865 Methods of inhibiting bone loss
12/19/1995US5476847 Treating cardiovascular, gastrointestinal, urogenital disorders
12/19/1995CA1337764C 1,4-dihydropyridine derivatives and pharmaceutical composition thereof
12/18/1995CA2150741A1 Pediatric lipid emulsion
12/14/1995WO1995033840A1 Recombinant viruses, preparation and use thereof in gene therapy
12/14/1995WO1995033752A1 Endothelin receptor antagonists
12/14/1995WO1995033750A1 Corticotropin releasing factor antagonists
12/14/1995WO1995033723A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and thiomorpholines as calcium channel antagonists
12/14/1995WO1995033722A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and tiomorpholines as calcium channel antagonists
12/14/1995WO1995033466A1 Pyridylbisphosphonates for use as a therapeutical agent
12/14/1995WO1995033455A1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof
12/14/1995WO1995028426A3 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
12/14/1995CA2191996A1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof
12/13/1995EP0686625A1 Anthranilic acid derivative
12/13/1995EP0686396A1 Enteral composition containing native micellar casein
12/13/1995EP0686164A1 Intrinsic inhibitors of aldose reductase
12/12/1995US5475113 Tetrahydronaphthyl and thiazole, oxazole or imidazole substituted ethene derivatives having retinoid-like activity, reduced skin toxicity and reduced teratogenecity
12/12/1995US5475106 Agonist for cholecystokinin and gastrin receptors; nervous system, gastrointestinal disorders
12/12/1995US5475022 Treating acne
12/12/1995US5475006 Mixed oxidation products which cannot form Vitamin A
12/12/1995US5474993 7-oxo-6-amino-4-thia-1-azabicycl(3.2.0) heptanes; anticholesterol agents
12/12/1995US5474987 Methods of using low molecular weight heparins treatment of pathological processes
12/12/1995US5474978 Insulin analog formulations
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/07/1995WO1995032972A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/07/1995WO1995032970A1 (a)-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/07/1995WO1995032948A1 Quinoline derivatives as tachykinin nk3 receptor antagonists
12/07/1995WO1995032730A1 A pharmaceutical preparation comprising glucagon
12/07/1995WO1995032728A1 Inhibition of attachment of h. influenzae to human cells
12/07/1995WO1995032721A1 Cellular factors that regulate the expression of genes encoding proteins involved in cholesterol homeostasis
12/07/1995WO1995032715A1 Nitric oxide donor composition and method for treatment of anal disorders
12/07/1995WO1995032627A1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/07/1995WO1995025749A3 Eating suppressant peptides
12/07/1995DE4419247A1 New pyrrolizine keto-acid, keto-ester and carboxamide derivs.
12/07/1995DE4419246A1 New hetero-aryl substd. pyrrolizine derivs.
12/07/1995CA2191467A1 Cellular factors that regulate the expression of genes encoding proteins involved in cholesterol homeostasis
12/07/1995CA2191317A1 A pharmaceutical preparation comprising glucagon
12/07/1995CA2190610A1 Inhibition of attachment of h. influenzae to human cells
12/06/1995EP0684958A1 Polymers containing guanidino groups for use in therapy
12/06/1995EP0684949A1 Chemical compounds
12/06/1995EP0684945A1 Heterocyclic-substituted alkyl amide acat inhibitors
12/06/1995EP0684827A1 USE OF 26,26,26,27,27,27-HEXAFLUORO-1$g(a),25-DIHYDROXYCHOLECALCIFEROL FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS
12/06/1995EP0647131B1 Dermatological agent for aiding oxygen transport in the skin
12/06/1995EP0500847B1 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
12/06/1995EP0495106B1 Osteogenesis promoter
12/06/1995EP0484340B1 Treatment to reduce edema for brain and musculature injuries
12/06/1995EP0423318B1 Use of c5-c6 esters for the manufacture of a therapeutic composition for cholesterol gallstone dissolution
12/06/1995CN1112918A Fluorinated vitamin D3 derivative
12/06/1995CN1112914A Process for the preparation of allyl quinone derivatives, and intermediates
12/05/1995US5473049 Process for obtaining proinsulin possessing correctly linked cystine bridges
12/05/1995US5472980 Parental administration of pyruyate precursors
12/05/1995US5472977 Administering 3,4-(diphenyl)chromans
12/05/1995US5472968 Spiro[cycloalkylbenzene-1,1'-(1',2',3',4'-tetrahydro-isoquinolines)] having neuroprotective properties
12/05/1995CA2047903C Calcitonin-containing emulsion for nasal administration
11/1995
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995032205A1 Tricyclic dicarbonyl derivatives
11/30/1995WO1995031996A1 Materials and methods for treatment of plaquing diseases
11/30/1995WO1995031987A1 Use of pteridine derivatives as no-synthase inhibitors
11/30/1995DE4418096A1 Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase The use of pteridine derivatives as inhibitors of NO synthase
11/30/1995CA2189776A1 Tricyclic dicarbonyl derivatives
11/29/1995EP0684042A2 Oral solid pharmaceutical compositions containing as active ingredient gemfibrozil and process for preparing them
11/29/1995EP0683775A1 Heterocyclic 4-aminomethylpiperidine derivatives, their preparation and application in therapy
11/29/1995EP0683774A1 Hypolipidaemic compounds
11/29/1995EP0632726A4 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability.
11/29/1995CN1112786A 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity
11/29/1995CN1112560A Piperidine derivatives and anti-platelet agents containing the same
11/29/1995CN1112420A Orally administerable pharmaceutical formulations
11/28/1995US5470981 Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
11/28/1995US5470965 Complexable heterogenous oligosaccharides and alpha-hydosanes having therapeutical activity, process for their preparation and related pharmaceutical compositions
11/28/1995US5470952 Interleukin antagonists
11/28/1995US5470879 4-hydroxyisoleucine or lactone thereof
11/28/1995US5470877 Causing carcinoma regression
11/28/1995US5470864 Glycine amide derivatives containing pyridine or pyridine-N-oxide, anticholesterol, antiinflammatory
11/28/1995US5470858 Derivatives of (hetero)aromatic ethers and thioethers having antihyperlipidemic activity, process for their preparation and pharmaceutical compositions containing them
11/28/1995US5470839 Enteral diet and method for providing nutrition to a diabetic
1 ... 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 ... 1298